Some Things that You Should Know Regarding Bipolar Depression
Know that bipolar disorder is one type of condition that would affect all kinds of people. Both children and adults would get affected by such kind of condition. Such is a fact that you must understand. Women would suffer the most from this kind of depression that is called bipolar depression disorder.
This isn’t very strange or far-fetched in any case, since even when the women would suffer from such regular bipolar kind of depression or the depressive disorder, they would often spend more time depressed than they do being manic. This isn’t to say that only the women are depressive, the men also are and they may get affected by such condition.
The bipolar kind of disorder is also known as manic depression since such is a mental condition wherein you interchange often between such phases of depression and mania. If you suffer from such bipolar depression, you won’t have to spend a lot of time being manic as you spend getting depressed.
Such kind of depression is a form of disorder and you must understand that it is easy to mistakenly diagnose as bipolar disorder because of the sameness of these symptoms. Because of this, the doctor must have to keep you around for a long time when they would try to diagnose the condition that you have. It certainly won’t be flattering to either of you when you are treated for a wrong thing.
The bipolar affective disorder is another name for such bipolar disorder or the manic-depressive illness. However, you don’t want to mistake such for bipolar depression disorder. Such is related with those symptoms of such depressive phase of bipolar disorder but only a few of the mania.
Monotherapy trials against the placebo is the gold-standard design when determining the efficacy in treating bipolar depression. When such efficacy would be proven as monotherapy, the new compounds can be tested in the adjunctive-medication placebo-controlled trials. Those younger adults, without such established need for the long-term medication can be suitable for those clinical trials that require placebo-controls. The switch to mania or such hypomania can be a consequence of the active treatment for such bipolar depression.
Some medications like the tricyclic antidepressants as well as venlafaxine can be more likely to prove switch unlike the others but such increased rate of the switch can’t be seen until around ten weeks of treatment. Hence, the 12-week trials against placebo are required to determine such risk of switch and to establish such continuing effects. You should know that careful assessment at 6-8 weeks are required to make sure that the patients who fail to respond won’t continue in the study for the unacceptable periods of time.